News Releases
Pharmaceuticals
The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.
Most Read
- Aug 08, 2013, 13:00 ET Top 100 College Party Schools for 2013-2014
- Sep 26, 2013, 07:15 ET GQ Names 20 Worst Sports Franchises Of All Time
- Jul 05, 2013, 14:51 ET Don't miss the world's first free iPhone data recovery software from EaseUS
Most Emailed
- Sep 27, 2013, 06:07 ET Phoenix Defrauds Stimulus With Phony Kidnap Statistics Full Disclosure Network(R) TV Video-Internet Series
- Sep 25, 2013, 06:07 ET International Expert: UN + U.S. Statistics = 3rd World Literacy in So. California In A Full Disclosure Network(R) TV-Internet Series
- Sep 25, 2013, 07:07 ET Liberty Mutual Coach Of The Year Returns For Eighth Season, Honoring College Football's Top Leaders On The Field And In The Community
Organizations in the News
The organizations with the most activity in PR Newswire's News Room
Investors' Reports Analysts' Corner AAA Research ReportsJournalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Download our 2013 SEC Filing Calendar
Our 2013 SEC Calendar includes all required SEC filings deadlines and holiday closures
New! View News by location
- < Prev
1
- Next >
-
13:33 ET
Holy Name Medical Center Introduces Radium 223, Xofigo®, Novel Treatment For Prostate Cancer
Holy Name Medical Center's Cancer Center announces today the introduction of Xofigo® (radium 223 dichloride) for the treatment of select... -
13:11 ET
OphthaliX to Present at the Ophthalmology Futures European Forum
OphthaliX Inc. (OTC BB: OPLI), announced today that Dr. Sari Fishman, Director of Clinical Affairs, will deliver a company presentation at the... -
12:19 ET
Equatorial Guinea Supports Malaria Vaccine Trial
President Obiang Visits Sanaria Facilities in Support of the Country's Fight Against Malaria Equatorial Guinea's President Obiang... -
11:48 ET
Another Successful FDA Inspection at a Hovione site the 12th Successful Inspection in 18 Months
Hovione's plant in Loures, Portugal has successfully passed a GMP and Postmarket Approval inspection by FDA. The inspection, carried out by Mrs.... -
11:30 ET
Adamas Pharmaceuticals presenta datos clínicos positivos para ADS-5102, un tratamiento para la disquinesia inducida por levodopa, en el Congreso Mundial del Parkinson
- Los resultados de la prueba EASED fase 2/3 demuestran un incremento de aproximadamente tres horas de período de respuesta a los medicamentos... -
11:30 ET
Adamas Pharmaceuticals Presents Positive Clinical Data For ADS-5102, A Treatment For Levodopa-Induced Dyskinesia, At The World Parkinson's Congress
Adamas Pharmaceuticals, Inc. presented positive results today from the Phase 2/3 EASED™ clinical trial of ADS-5102 at the World Parkinson's... -
10:58 ET
Sarissa Capital Issues Open Letter Regarding Astex Pharmaceuticals
Sarissa Capital issues the following letter regarding Astex Pharmaceuticals, Inc. (NASDAQ: ASTX): We are one of Astex's largest shareholders,... -
10:57 ET
New ALR-LRI Collaboration to Accelerate New Treatments for Lupus
Today, the Alliance for Lupus Research (ALR) and the Lupus Research Institute (LRI) announced a trailblazing cooperative project to speed up the... -
10:45 ET
Marken-Bekanntmachung zum Moskauer Warenlager
- Globales Lagernetzwerk von Marken erweitert sich auf sieben; strategisch auf Kurs Marken verkündete heute die Ergänzung... -
10:37 ET
Marken annonce un entrepôt à Moscou
- Le réseau mondial d'entrepôts de Marken s'élargit à sept ; Stratégie sur les rails Marken a aujourd'hui... -
10:16 ET
PharmaPoint: Alzheimer's Disease - US Drug Forecast and Market Analysis to 2022
Reportlinker.com announces that a new market research report is available in its catalogue: PharmaPoint: Alzheimer's Disease - US Drug... -
09:52 ET
Rafarma Pharmaceuticals, Inc. (RAFA) announces consolidation of financial reports in preparation for PCAOB-Registrant Audit.
Rafarma Pharmaceuticals (OTC:RAFA), which previously announced plans for a full audit and a streamlining of its corporate structure, plans to... -
09:40 ET
MO BIO Laboratories, Inc. launches a new kit for rapid release of microbial DNA from swabs for PCR analysis
MO BIO Laboratories, Inc., the leader in microbial, stool, plant, and soil nucleic acid purification, announces the launch of the... -
09:23 ET
CPhI Annual Expert Industry Report: Part I
Piramal Enterprises, Fujifilm Diosynth Biotechnologies and Vision Consulting Outline Market Predictions ADCs, multiuse facilities and regulatory... -
09:11 ET
New Pooled Analysis Reports Pradaxa® (dabigatran etexilate mesylate) May Be Associated With Better Patient Outcomes After a Major Bleeding Event Compared to Warfarin
Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from a retrospective analysis comparing clinical management and patient... -
09:00 ET
Data on Brisdelle™ (Paroxetine) Capsules, the First and Only FDA-Approved Non-Hormonal Therapy for Moderate to Severe Vasomotor Symptoms Associated with Menopause, to be Presented at the 2013 Annual Meeting of The North American Menopause Society
Noven Pharmaceuticals, Inc., today announced that 11 presentations, featuring data analyses from its Phase 3 pivotal trials that supported... -
09:00 ET
Actavis plc Names Board of Directors
Actavis plc (NYSE: ACT) today announced the appointment of its Board of Directors, effective until the next annual meeting of... -
08:54 ET
Pivotal Therapeutics to close equity portion of financing; Enters into $5,000,000 debt financing agreement
WOODBRIDGE, ON, Oct. 2, 2013 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CNSX: PVO), a specialty pharmaceutical company with a focus... -
08:10 ET
GW Pharmaceuticals Announces New Sativex® Data at ECTRIMS
GW Pharmaceuticals plc (AIM: GWP, Nasdaq: GWPH, "GW") announced that data from new MS spasticity studies (clinical trial data, observational study... -
08:00 ET
BioNano Genomics Raises $10 Million Financing To Advance Irys System For Human Genome Analysis
BioNano Genomics announced today a $10 million financing to support the ongoing development and commercialization of the IrysTM System for...
- < Prev
1
- Next >
